Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
Gastric cancer is a heterogeneous disease with diverse histological and genomic subtypes, making it difficult to demonstrate treatment efficacy in clinical trials. However, recent efforts have been made to identify molecular biomarkers with prognostic and predictive implications to better understand...
Main Authors: | Yasushi Sato, Koichi Okamoto, Yutaka Kawano, Akinari Kasai, Tomoyuki Kawaguchi, Tamotsu Sagawa, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/14/4646 |
Similar Items
-
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
by: Daniele Lavacchi, et al.
Published: (2023-03-01) -
State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
by: Basile D, et al.
Published: (2021-11-01) -
Targeted Therapies and Developing Precision Medicine in Gastric Cancer
by: Rille Pihlak, et al.
Published: (2023-06-01) -
Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
by: Bo Xu, et al.
Published: (2022-06-01) -
CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
by: Canming Wang, et al.
Published: (2023-08-01)